The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Version 3 2024-06-19, 10:31Version 3 2024-06-19, 10:31
Version 2 2024-06-03, 19:37Version 2 2024-06-03, 19:37
Version 1 2022-03-25, 07:58Version 1 2022-03-25, 07:58
journal contribution
posted on 2024-06-19, 10:31 authored by RCJ Bradlow, Michael BerkMichael Berk, PW Kalivas, SE Back, RA KanaanThe Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
History
Journal
CNS DrugsVolume
36Pagination
451-482Location
Berlin, GermanyPublisher DOI
Open access
- Yes
Link to full text
ISSN
1172-7047eISSN
1179-1934Language
EnglishPublication classification
C1 Refereed article in a scholarly journalPublisher
Springer NatureUsage metrics
Categories
Keywords
ACETYLCYSTEINE AUGMENTATIONCANNABIS USE DISORDERClinical NeurologyDOUBLE-BLINDLife Sciences & BiomedicineN-ACETYL-CYSTEINENeurosciences & NeurologyOBSESSIVE-COMPULSIVE DISORDEROXIDATIVE STRESSPharmacology & PharmacyPILOT TRIALPLACEBO-CONTROLLED TRIALPsychiatryScience & TechnologySELF-INJURIOUS-BEHAVIORSKIN-PICKING3202 Clinical sciences3205 Medical biochemistry and metabolomics
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC